IDH2 and central nervous system cancer: Moreover, gliomas with mutated IDH status and those with 1p/19q codeletion are associated with higher SHANK2 expression, suggesting a potential link between SHANK2 and these genetic alterations (Figures 1(e) and 1(f)).